Drug Type Small molecule drug |
Synonyms Beta-lactum antibiotic-tarocin fixed dose combination (Prokaryotics), TarO inhibitor(Prokaryotics) |
Action inhibitors |
Mechanism Bacterial outer membrane proteins inhibitors |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| MRSA - Methicillin resistant Staphylococcus aureus infection | Preclinical | United States | 01 Jan 2026 | |
| Staphylococcal Infections | Preclinical | United States | - |





